Stockreport

CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance [Yahoo! Finance]

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF ? Q3 2025 Net Income of $108.6 million; Adjusted EBITDA of $71.9 million ? ? FY 2025 Pro Forma Net Revenue Guidance Raised to a Range of $390 to $410 million ? ? Co [Read more]